Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)

INTRODUCTION: Dotinurad is a newer urate-lowering agent that selectively inhibits urate transporter 1 in the renal proximal tubule and increases urinary urate excretion. Currently, little is known about the clinical efficacies of dotinurad in patients with hyperuricemia and hypertension. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Atsushi, Taguchi, Isao, Hisauchi, Itaru, Yoshida, Hisako, Shimabukuro, Michio, Hongo, Hiroshi, Ishikawa, Tetsuya, Kadokami, Toshiaki, Yagi, Shusuke, Sata, Masataka, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351195/
https://www.ncbi.nlm.nih.gov/pubmed/37461063
http://dx.doi.org/10.1186/s40001-023-01208-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351195/
https://www.ncbi.nlm.nih.gov/pubmed/37461063
http://dx.doi.org/10.1186/s40001-023-01208-1

Ejemplares similares